Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating activities:
Net loss	$ (3,386,417)	$ (187,799)
Adjustments to reconcile net loss to net cash used in operating activities:
Non-cash stock-based compensation	81,053	1,139,636
Depreciation and amortization	4,429	6,453
Reduction in carrying amount of right-of-use asset	45,179	55,806
Changes in assets and liabilities:
Accounts receivable		(4,000,000)
Prepaid expenses and other assets	(554,172)	(489,180)
Accounts payable, accrued liabilities and other liabilities	111,353	(319,409)
Operating lease liabilities	(29,825)	(59,459)
Net cash used in operating activities	(3,728,400)	(3,853,952)
Financing activities:
Proceeds from issuance of common stock and exercise of common stock options		20,212,175
Common stock issuance costs		(118,352)
Proceeds from issuance of equity awards under ESPP		6,110
Net cash provided by financing activities		20,099,933
Effect of exchange rate changes on cash and cash equivalents	(7,301)	19,096
Net change in cash and cash equivalents	(3,735,701)	16,265,077
Cash and cash equivalents, beginning of period	71,430,954	60,036,763
Cash and cash equivalents, end of period	$ 67,695,253	$ 76,301,840